Researchers in the United States and Taiwan reveal the potential of a new protein peptide vaccine to prevent infection with drugs that cause severe acute respiratory...
Recent editorial Nature nanotechnology A messenger RNA (mRNA) -based vaccine developed to deliver the gene sequence of a specific SARS-CoV-2 viral protein to a host cell...
There is much evidence that obesity, hypertension and cardiovascular disease contribute significantly to adverse outcomes following coronavirus disease 2019 (COVID-19). It is rational to apply the...
The COVID-19 pandemic continues to spread worldwide, affecting more than 62.26 million people. Due to the rapid spread of the causative agent, Severe Acute Respiratory Syndrome...
The COVID-19 pandemic has affected more than 60 million people worldwide, with nearly 1.43 million suffering from severe COVID-19 disease and nearly 40 million recovering. Severe...
How long does immunity to Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) last after the initial infection? This is one of the important and difficult questions...
Recent Comments